SEARCH

SEARCH BY CITATION

References

  • 1
    Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007; 114: 97109.
  • 2
    Rao JS. Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer 2003; 3: 489501.
  • 3
    Demuth T, Berens M. Molecular mechanisms of glioma cell migration and invasion. J Neurooncol 2004; 70: 21728.
  • 4
    Levičar N, Nuttall RK, Lah TT. Proteases in brain tumour progression. Acta Neurochir (Wien) 2003; 145: 82538.
  • 5
    Lah TT, Durán Alonso MB, Van Noorden CJ. Antiprotease therapy in cancer: hot or not? Expert Opin Biol Ther 2006; 6: 25779.
  • 6
    Strojnik T, Kos J, Zidanik B, Golouh R, Lah T. Cathepsin B immunohistochemical staining in tumor and endothelial cells is a new prognostic factor for survival in patients with brain tumors. Clin Cancer Res 1999; 5: 55967.
  • 7
    Strojnik T, Kavalar R, Trinkaus M, Lah TT. Cathepsin L in glioma progression: comparison with cathepsin B. Cancer Detect Prev 2005; 29: 44855.
  • 8
    Flannery T, McQuaid S, McGoohan C, McConnell RS, McGregor G, Mirakhur M, Hamilton P, Diamond J, Cran G, Walker B, Scott C, Martin L, et al. Cathepsin S expression: an independent prognostic factor in glioblastoma tumours—a pilot study. Int J Cancer 2006; 119: 85460.
  • 9
    Lah TT, Strojnik T, Levicar N, Bervar A, Zajc I, Pilkington G, Kos J. Clinical and experimental studies of cysteine cathepsins and their inhibitors in human brain tumors. Int J Biol Markers 2000; 15: 903.
  • 10
    Lakka SS, Gondi CS, Yanamandra N, Olivero WC, Dinh DH, Gujrati M, Rao JS. Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis. Oncogene 2004; 23: 46819.
  • 11
    Gole B, Durán Alonso MB, Dolenc V, Lah T. Post-translational regulation of cathepsin B, but not of other cysteine cathepsins, contributes to increased glioblastoma cell invasiveness in vitro. Pathol Oncol Res 2009; 15: 71123.
  • 12
    Sivaparvathi M, Yamamoto M, Nicolson GL, Gokaslan ZL, Fuller GN, Liotta LA, Sawaya R, Rao JS. Expression and immunohistochemical localization of cathepsin L during the progression of human gliomas. Clin Exp Metastasis 1996; 14: 2734.
  • 13
    Levičar N, Dewey RA, Daley E, Bates TE, Davies D, Kos J, Pilkington GJ, Lah TT. Selective suppression of cathepsin L by antisense cDNA impairs human brain tumor cell invasion in vitro and promotes apoptosis. Cancer Gene Ther 2003; 10: 14151.
  • 14
    Flannery T, Gibson D, Mirakhur M, McQuaid S, Greenan C, Trimble A, Walker B, McCormick D, Johnston PG. The clinical significance of cathepsin S expression in human astrocytomas. Am J Pathol 2003; 163: 17582.
  • 15
    Zajc I, Hreljac I, Lah T. Cathepsin L affects apoptosis of glioblastoma cells: a potential implication in the design of cancer therapeutics. Anticancer Res 2006; 26: 335764.
  • 16
    Kos J, Lah TT. Cystatins in cancer. In: Zerovnik E, Kopitar-Jerala N, eds. Human stefins and cystatins. New York: Nova Science Publishers Inc., 2006. 15365.
  • 17
    Konduri SD, Yanamandra N, Siddique K, Joseph A, Dinh DH, Olivero WC, Gujrati M, Kouraklis G, Swaroop A, Kyritsis AP, Rao JS. Modulation of cystatin C expression impairs the invasive and tumorigenic potential of human glioblastoma cells. Oncogene 2002; 21: 870512.
  • 18
    Nakabayashi H, Hara M, Shimuzu K. Clinicopathologic significance of cystatin C expression in gliomas. Hum Pathol 2005; 36: 100815.
  • 19
    Lah TT, Obermajer N, Durán Alonso MB, Kos J. Cysteine cathepsins and cystatins as cancer biomarkers. In: Edwards D, Hoyer-Hansen G, Blasi D, Sloane BF, eds. The cancer degradome. Proteases and cancer biology. New York: Springer Science, 2008. 585623.
  • 20
    Rempel SA, Rosenblum ML, Mikkelsen T, Yan PS, Ellis KD, Golembieski WA, Sameni M, Rozhin J, Ziegler G, Sloane BF. Cathepsin B expression and localization in glioma progression and invasion. Cancer Res 1994; 54: 602731.
  • 21
    Demchik LL, Sameni M, Nelson K, Mikkelsen T, Sloane BF. Cathepsin B and glioma invasion. Int J Dev Neurosci 1999; 17: 48394.
  • 22
    Friedl P, Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 2003; 3: 36274.
  • 23
    Claes A, Idema AJ, Wesseling P. Diffuse glioma growth: a guerilla war. Acta Neuropathol 2007; 114: 44358.
  • 24
    Chin L, Gray JW. Translating insights from the cancer genome into clinical practice. Nature 2008; 452: 55363.
  • 25
    Strojnik T, Kavalar R, Lah TT. Experimental model and immunohistochemical analyses of U87 human glioblastoma cell xenografts in immunosuppressed rat brains. Anticancer Res 2006; 26: 2887900.
  • 26
    Niclou SP, Danzeisen C, Eikesdal HP, Wiig H, Brons NH, Poli AM, Svendsen A, Torsvik A, Enger PØ, Terzis JA, Bjerkvig R. A novel eGFP-expressing immunodeficient mouse model to study tumor-host interactions. FASEB J 2008; 22: 31208.
  • 27
    Demuth T, Rennert JL, Hoelzinger DB, Reavie LB, Nakada M, Beaudry C, Nakada S, Anderson EM, Henrichs AN, McDonough WS, Holz D, Joy A, et al. Glioma cells on the run—the migratory transcriptome of 10 human glioma cell lines. BMC Genomics 2008; 9: 54.
  • 28
    Mariani L, Beaudry C, McDonough WS, Hoelzinger DB, Demuth T, Ross KR, Berens T, Coons SW, Watts G, Trent JM, Wei JS, Giese A, et al. Glioma cell motility is associated with reduced transcription of proapoptotic and proliferation genes: a cDNA microarray analysis. J Neurooncol 2001; 53: 16176.
  • 29
    Bellail AC, Hunter SB, Brat DJ, Tan C, Van Meir EG. Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. Int J Biochem Cell Biol 2004; 36: 104669.
  • 30
    Sahai E. Mechanisms of cancer cell invasion. Curr Opin Genet Dev 2005; 15: 8796.
  • 31
    Sameni M, Elliot E, Ziegler G, Fortgens PH, Dennison C, Sloane BF. Cathepsins B and D are localised at the surface of human breast cancer cells. Pathol Oncol Res 1995; 7: 4353.
  • 32
    Kim KJ, Wang L, Su YC, Gillespie GY, Salhotra A, Lal B, Laterra J. Systemic anti-hepatocyte growth factor monoclonal antibody therapy induces the regression of intracranial glioma xenografts. Clin Cancer Res 2006; 12: 12928.
  • 33
    Saidi A, Hagedorn M, Allain N, Verpelli C, Sala C, Bello L, Bikfalvi A, Javerzat S. Combined targeting of interleukin-6 and vascular endothelial growth factor potently inhibits glioma growth and invasiveness. Int J Cancer 2009; 125: 105464.
  • 34
    Parker BS, Ciocca DR, Bidwell BN, Gago FE, Fanelli MA, George J, Slavin JL, Möller A, Steel R, Pouliot N, Eckhardt BL, Henderson MA, et al. Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer. J Pathol 2008; 214: 33746.
  • 35
    Strojnik T, Zajc I, Bervar A, Zidanik B, Golouh R, Kos J, Dolenc V, Lah T. Cathepsin B and its inhibitor stefin A in brain tumors. Pflugers Arch 2000; 439( 3 Suppl): R122R123.
  • 36
    Lah TT, Kos J, Blejec A, Frković-Georgio S, Golouh R, Vrhovec I, Turk V. The expression of lysosomal proteinases and their inhibitors in breast cancer: possible relationship to prognosis of the disease. Pathol Oncol Res 1997; 3: 8999.
  • 37
    Kuopio T, Kankaanranta A, Jalava P, Krongvist P, Kotkansalo T, Weber E, Collan Y. Cysteine proteinase inhibitor cystatin A in breast cancer. Cancer Res 1998; 58: 4326.
  • 38
    Sinha AA, Quast BJ, Wilson MJ, Fernandes ET, Reddy PK, Ewig SL, Gleason DF. Prediction of lymph node metastasis by the raio of cathepsins B to Stefi A in patients with prostate carcinoma. Cancer 2002; 94: 314149.
  • 39
    Ehtesham M, Winston JA, Kabos P, Thompson RC. CXCR4 expression mediates glioma cell invasiveness. Oncogene 2006; 25: 28016.
  • 40
    Strojnik T, Kavalar R, Zajc I, Diamandis EP, Oikonomopoulou K, Lah TT. Prognostic impact of CD68 and kallikrein 6 in human glioma. Anticancer Res 2009; 29: 326979.
  • 41
    Colin C, Voutsinos-Porche B, Nanni I, Fina F, Metellus P, Intagliata D, Baeza N, Bouvier C, Delfino C, Loundou A, Chinot O, Lah T, et al. High expression of cathepsin B and plasminogen activator inhibitor type-1 are strong predictors of survival in glioblastomas. Acta Neuropathol 2009; 118: 74554.
  • 42
    Bervar A, Zajc I, Sever N, Katunuma N, Sloane BF, Lah TT. Invasiveness of transformed human breast epithelial cell lines is related to cathepsin B and inhibited by cysteine protease inhibitors. Biol Chem 2003; 384: 44755.
  • 43
    Gocheva V, Zeng W, Ke D, Klimstra D, Reinheckel T, Peters C, Hanahan D, Joyce JA. Distinct roles for cysteine cathepsin genes in multistage tumorigenesis. Genes Dev 2006; 20: 54356.
  • 44
    Dennhöfer R, Kurschat P, Zigrino P, Klose A, Bosserhoff A, van Muijen G, Krieg T, Mauch C, Hunzelmann N. Invasion of melanoma cells into dermal connective tissue in vitro: evidence for an important role of cysteine proteases. Int J Cancer 2003; 106: 31623.